Clinical Nephrology » Serum and urinary interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis: role in determination of efficacy of antiviral therapy in combination with rituximab

Serum and urinary interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis: role in determination of efficacy of antiviral therapy in combination with rituximab

Yu.V. Korotchaeva, L.V. Kozlovskaya, N.B. Gordovskaya, A.I. Speranskii, S.Yu. Milovanova, S.V. Roschupkina

Role of determination of serum and urinary level of interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis and efficacy of it’s treatment.

Keywords: HCV-associated cryoglobulinemic nephritis, interleukin-6, rituximab, activity

Read entire article

Serum and urinary interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis: role in determination of efficacy of antiviral therapy in combination with rituximab

Similar Articles